IDH2 R140Q
|
AML
|
IDH2 R140Q
|
AML
|
venetoclax + enasidenib Sensitive: C3 – Early Trials
|
venetoclax + enasidenib Sensitive: C3 – Early Trials
|
IDH2 R140Q
|
AML
|
IDH2 R140Q
|
AML
|
enasidenib Sensitive: D – Preclinical
|
enasidenib Sensitive: D – Preclinical
|